Phase 3 trial data show a synthetic semaglutide injection provides glycemic control comparable to Ozempic in patients with type 2 diabetes.

The company confirmed that its partner Orbicular, along with a Canadian front-end partner, received approval from Health ...

OneSource Specialty Pharma announced that its partner Orbicular, along with its Canadian front-end partner, has received approval from Health Canada for a generic version of Ozempic (semaglutide ...

Today, Health Canada authorized a generic semaglutide injection. This is the first generic semaglutide authorized by Health Canada, and the first to be approved in the G7. Health Canada is currently ...

Dr. Reddy’s Laboratories Ltd. announced that it has received a Notice of Compliance (NOC) from Health Canada for its generic ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly ...

Semaglutide (Ozempic®, Wegovy®, Rybelsus®) comes in both injection and oral form. But beyond how you take it, what’s the difference? And which form is more effective for weight loss? Semaglutide ...

Health Canada has granted Dr. Reddy’s Laboratories a Notice of Compliance for a generic version of semaglutide injection, ...

Ozempic and other GLP-1 agonists can aid in blood sugar and weight management and function as treatments for for people with diabetes, obesity and some other health conditions. Semaglutide is the ...

The MHRA has approved an update to the product information of Wegovy® (semaglutide injection) FlexTouch™, allowing it to be delivered to patients through controlled shipment at temperatures below 30°C ...

The newly approved oral formulation features a smaller pill size in 1.5mg, 4mg, and 9mg strengths while maintaining the efficacy and safety profile of the previous oral semaglutide version.